Literature DB >> 19060921

HAND1 gene expression is negatively regulated by the High Mobility Group A1 proteins and is drastically reduced in human thyroid carcinomas.

J Martinez Hoyos1, A Ferraro, S Sacchetti, S Keller, I De Martino, E Borbone, P Pallante, M Fedele, D Montanaro, F Esposito, P Cserjesi, L Chiariotti, G Troncone, A Fusco.   

Abstract

HMGA1 proteins exert their major physiological function during embryonic development and play a critical role in neoplastic transformation. Here, we show that Hand1 gene, which codes for a transcription factor crucial for differentiation of trophoblast giant cells and heart development, is upregulated in hmga1 minus embryonic stem cells. We demonstrate that HMGA1 proteins bind directly to Hand1 promoter both in vitro and in vivo and inhibit Hand1 promoter activity. We have also investigated HAND1 expression in human thyroid carcinoma cell lines and tissues, in which HMGA proteins are overexpressed, with respect to normal thyroid; an inverse correlation between HMGA1 and HAND1 expression was found in all thyroid tumor histotypes. A correlation between HAND1 gene repression and promoter hypermethylation was found in anaplastic carcinomas but not in other thyroid tumor histotypes. Therefore, we can hypothesize that HMGA1 overexpression plays a key role on HAND1 silencing in differentiated thyroid carcinomas and that promoter hypermethylation occurs in later stages of thyroid tumor progression. Finally, the restoration of the HAND1 gene expression reduces the clonogenic ability of two human thyroid carcinoma-derived cell lines, suggesting that HAND1 downregulation may have a role in the process of thyroid carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19060921     DOI: 10.1038/onc.2008.438

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  10 in total

Review 1.  The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development.

Authors:  T F Sumter; L Xian; T Huso; M Koo; Y-T Chang; T N Almasri; L Chia; C Inglis; D Reid; L M S Resar
Journal:  Curr Mol Med       Date:  2016       Impact factor: 2.222

2.  HMGA1-pseudogene expression is induced in human pituitary tumors.

Authors:  Francesco Esposito; Marco De Martino; Daniela D'Angelo; Paula Mussnich; Gerald Raverot; Marie-Lise Jaffrain-Rea; Filippo Fraggetta; Jacqueline Trouillas; Alfredo Fusco
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 3.  High Mobility Group A1 (HMGA1): Structure, Biological Function, and Therapeutic Potential.

Authors:  Lu Wang; Ji Zhang; Min Xia; Chang Liu; Xuyu Zu; Jing Zhong
Journal:  Int J Biol Sci       Date:  2022-07-04       Impact factor: 10.750

Review 4.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

5.  HAND1 and BARX1 Act as Transcriptional and Anatomic Determinants of Malignancy in Gastrointestinal Stromal Tumor.

Authors:  Matthew L Hemming; Shannon Coy; Jia-Ren Lin; Jessica L Andersen; Joanna Przybyl; Emanuele Mazzola; Amr H Abdelhamid Ahmed; Matt van de Rijn; Peter K Sorger; Scott A Armstrong; George D Demetri; Sandro Santagata
Journal:  Clin Cancer Res       Date:  2021-01-15       Impact factor: 13.801

6.  Reconstruction and analysis of transcription factor-miRNA co-regulatory feed-forward loops in human cancers using filter-wrapper feature selection.

Authors:  Chen Peng; Minghui Wang; Yi Shen; Huanqing Feng; Ao Li
Journal:  PLoS One       Date:  2013-10-29       Impact factor: 3.240

Review 7.  HMGA1-pseudogenes and cancer.

Authors:  Marco De Martino; Floriana Forzati; Claudio Arra; Alfredo Fusco; Francesco Esposito
Journal:  Oncotarget       Date:  2016-05-10

8.  TGF-β1 induces HMGA1 expression: The role of HMGA1 in thyroid cancer proliferation and invasion.

Authors:  Jing Zhong; Chang Liu; Qing-Hai Zhang; Ling Chen; Ying-Ying Shen; Ya-Jun Chen; Xi Zeng; Xu-Yu Zu; Ren-Xian Cao
Journal:  Int J Oncol       Date:  2017-04-07       Impact factor: 5.650

9.  miR-155 is positively regulated by CBX7 in mouse embryonic fibroblasts and colon carcinomas, and targets the KRAS oncogene.

Authors:  Floriana Forzati; Marco De Martino; Francesco Esposito; Romina Sepe; Simona Pellecchia; Umberto Malapelle; Gianluca Pellino; Claudio Arra; Alfredo Fusco
Journal:  BMC Cancer       Date:  2017-03-04       Impact factor: 4.430

Review 10.  HMGA1 in cancer: Cancer classification by location.

Authors:  Yuhong Wang; Lin Hu; Yushuang Zheng; Lingchuan Guo
Journal:  J Cell Mol Med       Date:  2019-01-07       Impact factor: 5.310

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.